Antiphospholipid antibodies in paediatric systemic lupus erythematosus, juvenile chronic arthritis and overlap syndromes: Sle patients with both lupus anticoagulant and high-titre anticardiolipin antibodies are at risk for clinical manifestations related to the antiphospholipid syndrome

Rheumatology

Volumn 34, Issue 9, 1995, Pages 873-881

  Gattorno, M ^a   Buoncompagni, A ^a   Molinari, A C ^a   Barbano, G C ^a   Morreale, G ^a   Stalla, F ^a   Picco, P ^a   Mori, P G ^a   Pistoia, V ^a  

^a G GASLINI INSTITUTE   (Italy)

Author keywords

Anticardiolipin antibodies; Childhood systemic lupus erythematosus; Juvenile chronic arthritis; Lupus anticoagulant; Overlap syndromes

Indexed keywords

CARDIOLIPIN ANTIBODY; LUPUS ANTICOAGULANT; PHOSPHOLIPID ANTIBODY;

ADOLESCENT; ANTIBODY TITER; ANTIPHOSPHOLIPID SYNDROME; ARTICLE; BLOOD CLOTTING TIME; CHILD; CLINICAL ARTICLE; CLINICAL FEATURE; DEEP VEIN THROMBOSIS; ENZYME IMMUNOASSAY; FEMALE; FOLLOW UP; HEMOLYTIC ANEMIA; HIGH RISK PATIENT; HUMAN; JUVENILE RHEUMATOID ARTHRITIS; MALE; NEUROLOGIC DISEASE; PARTIAL THROMBOPLASTIN TIME; PRIORITY JOURNAL; PULMONARY HYPERTENSION; SYSTEMIC LUPUS ERYTHEMATOSUS;

ADOLESCENT; ANTIBODIES, ANTICARDIOLIPIN; ANTIBODIES, ANTIPHOSPHOLIPID; ANTIPHOSPHOLIPID SYNDROME; ARTHRITIS, JUVENILE RHEUMATOID; CHILD; CHILD, PRESCHOOL; FEMALE; HUMAN; LUPUS COAGULATION INHIBITOR; LUPUS ERYTHEMATOSUS, SYSTEMIC; MALE; RISK FACTORS; SUPPORT, NON-U.S. GOV'T; SYNDROME;

EID: 0028857818     PISSN: 14620324     EISSN: None     Source Type: Journal    
DOI: 10.1093/rheumatology/34.9.873     Document Type: Article

References (59)

1. Conley CL, Hartmann RC. A hemorragic disorder caused by circulating anticoagulant in patients with disseminated lupus erythematosus. J Clin Invest 1952;31:621-5.
2. Editorial. Lupus anticoagulant. Lancet 1984;1:1175.
3. Bowie EJ, Thompson JH Jr, Pascuzzi CA, Owen CA Jr. Thrombosis in systemic lupus erythematosus despite circulating anticoagulants. J Lab Clin Med 1963; 162:417-30.
4. Harris EN, Gharavi AE, Boey ML, Patel BM, Mack-worth-Young CG, Loizou S, Hughes GRV. Anticardi-olipin antibodies: detection by radioimmunoassay and association with thrombosis in systemic lupus erythematosus. Lancet 198301:1211-14.
5. Boey ML, Colaco CB, Gharavi AE, Elkon KB, Lotzon S, Hughes GRV. Thrombosis in systemic lupus erythematosus: striking association with the presence of circulating lupus anticoagulant. Br J Med 1983;287:1021-3.
6. Alarcon-Segovia D, Deleze M, Oria CV, Sanchez-Guerrero J, Gomez-Pacheco L, Cabiedes J, Fernandez L, Ponce de Leon D. Antiphospholipid antibodies and the antiphospholipid syndrome in systemic lupus erythematosus. A prospective analysis of 500 consecutive patients. Medicine 1989;68:353-6.
7. Asherson RA, Khamashta MA, Ordi-ros J, Derksen RHWM, Machin SJ, Barquinero J, Outt HH, Harris EN, Vilardell-Torres M, Hughes GRV. The 'primary antiphospholipid syndrome': major clinical and serological features. Medicine 1989;68:366-74.
8. Hughes GRV. The antiphospholipid syndrome: ten years on. Lancet 1993;342:341-4.
9. Harris EN. A reassessment of the APA syndrome. J Rheumatol 1990;17:733-5.
10. Love PE, Santoro SA. Antiphospholipid antibodies: anticardiolipin and the lupus anticoagulant in systemic lupus erythematosus (SLE) and in non-SLE disorders. Ann Intern Med 1990;112:682-98.
11. St Clair W, Jones B, Rogers JS, Crough M, Hrabovsky E. Deep venous thrombosis and a circulating anticoagulant in systemic lupus erythematosus. Am J Dis Child 1981;135:230-2.
12. MacKay RJ, Mennahem S, Ekert H. Deep vein thrombosis in association with a circulating endogenous anticoagulant. /Pediatr 1982;101:75-7.
13. Bernstein ML, Salusinsky-Sternbach M, Bellefluer M, Esseltine DW. Thrombotic and hemmorragic complications in children with the lupus anticoagulant. Am J Dis Child 1984;138:1132-5.
14. Appan S, Boey ML, Lim KW. Multiple thromboses in systemic lupus erythematosus. Arch Dis Child 1987; 62:739-41.
15. Kelley RE, Berger JR. Ischemic stroke in a girl with lupus anticoagulant Pediatr Neurol 1987;3:58-61.
16. Davies SM, Dunger DB. Systemic lupus erythematosus in a child with autoimmune thrombocytopenia purpura and circulating lupus anticoagulant. J Roy Soc Med 1987;80:186-90.
17. Pelkonen P, Simell O, Rasi V, Vaarala O. Venous thrombosis associated with lupus anticoagulant and anticardiolipin antibodies. Acta Pediatr Scand 1988; 77:767-72.
18. Ostuni PA, Lazzarin P, Pengo V, Ruffatti A, Schiavon F, Gambari P. Renal artery thrombosis and hypertension in a 13 year girl with antiphospholipid syndrome. Ann Rheum Dis 1990;49:184-7.
19. Ravelli A, Caporali R, Bianchi E, Montecucco C, Martini A. Anticardiolipin syndrome in childhood: a report of two cases. Clin Exp Rheumatol 1990;8:95-8.
20. Falcini F, Taccetti G, Trapani S, Tafi L, Petralli S, Matucci-Cerinic M. Primary antiphospholipid syndrome: a report of two pediatric cases. J Rheumatol 1991;18:1085-7.
21. Roddy SM, Giang DW. Antiphospholipid antibodies and stroke in an infant. Pediatrics 1991;87:933-5.
22. Moland Y, Arad A, Pinkhas J, Enyan N. Cerebral infarct associated with lupus anticoagulant in an adolescent girl: a case report with review of the literature. J Adol Health 1991;12:399-402.
23. Ura Y, Hara T, Mori Y, Matsuo M, Fujioka Y, Kuno T, Okue A, Miyazaki S. Development of Perthes’ disease in a 3-year-old boy with idiopathic thrombocytopenic purpura and antiphospholipid antibodies. Pediatr Hematol Oncol 1992;9:77-80.
24. Dungan D, Jay MS. Stroke in an early adolescent with systemic lupus erythematosus and coexistent antiphospholipid antibodies. Pediatrics 1992;90:96-9.
25. Ravelli A, Caporali R, Montecucco C, Martini A. Superior cava thrombosis in a child with antiphospholipid syndrome. J Rheumatol 1992;19:502-3.
26. Caporali R, Ravelli A, Ramenghi B, Montecucco C, Martini A. Antiphospholipid antibody associated thrombosis in juvenile chronic arthritis. Arch Dis Child 1992;67:1384-5.
27. May KP, West SG, Moulds J, Kotzin BL. Different manifestations of the antiphospholipid antibody syndrome in a family with systemic lupus erythematosus. Arthritis Rheum 1993;36:528-33.
28. Shergy WJ, Kredich DW, Pisetsky DS. The relationship of anticardiolipin antibodies to disease manifestation in pediatric systemic lupus erythematosus. J Rheumatol 1988;15:1389-94.
29. Ravelli A, Caporali R, Di Fuccia G, De Gennaro F, Zonta L, Montecucco C, Martini A. Anticardiolipin antibodies in pediatric systemic lupus erythematosus. Arch Pediatr Adolesc 1994;148:398-402.
30. Montes de Oca M, Babron MC, Bletry O, Broyer M, Courtecuisse V, Fontaine JL, Lorait C, Mery JF, Reinert P, Wechsler B, Levy M. Thrombosis in systemic lupus erythematosus: a French collaborative study. Arch Dis Child 1991;66:713-17.
31. Caporali R, Ravelli A, De Gennaro F, Neirotti G, Montecucco C, Martini A. Prevalence of anticardiolipin antibodies in juvenile chronic arthritis. Ann Rheum Dis 1991;50:599-601.
32. Molta C, Meyer O, Dosquet C, Montes de Oca, Babron MC, Danon F, Kaplan C, Clemenceau S, Castellano F, Levy M. Childhood onset systemic lupus erythematosus: antiphospholipid antibodies in 37 patients and their first-degree relatives. Pediatrics 1993;92:849-53.
33. Alarcon-Segovia D, Perez-Vazquez ME, Villa AR, Drenkard C, Cabiedes J. Preliminary classification criteria for the antiphospholipid syndrome within systemic lupus erythematosus. Semin Arthritis Rheum 1992;21: 275-86.
34. Tan EM, Cohen AS, Fries JF, Masi AT, McShane DJ, Rothfield NF, Shaller JG, Talal N, Winchester RJ. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1982;25:1271-7.
35. Buoncompagni A, Barbano GC, Pistoia V, Fasce L, Micalizzi C, Gusmano R, Cordone G, Cottafava F, Mori PG, Franchini E, Ferrarini M, Borrone C. Childhood systemic lupus erythematosus: a review of 30 cases. Clin Exp Rheumatol 1991;9:425-31.
36. Vitali C, Benrivelli W, Isenberg DA, Suidens JS, Snaith ML, Sciuto M, Neri R, Bombardieri S and the European Consensus Group for disease activity in SLE. European consensus group study for disease activity criteria in systemic lupus erythematosus: A descriptive analysis of the variables indicative of disease activity and their use in development of an activity score. Clin Exp Rheumatol 1992;10:541-7.
37. Ansell BM. Heberden oration: chronic arthritis in childhood. Ann Rheum Dis 1978;37:107-20.
38. Pistoia V, Buoncompagni A, Scribanis R, Fasce L, Alpigiani G, Cordone G, Ferrarini M, Borrone C, Cottafava F. Cyclosporin A in the treatment of juvenile chronic arthritis and childhood polymyositis/dermatomyositis. Result of a preliminary study. Clin Exp Rheumatol 1993;11:203-8.
39. Allen RC, St-Cyr C, Maddison PJ, Ansell BM. Overlap connective tissue syndromes. Arch Dis Child 1986; 61:284-8.
40. Harris EN. Antiphospholipid antibodies. Br J Haematol 1990;74:1-9.
41. McNeil HP, Richard JS, Chesterman CN, Krilis SA. Anti-phospholipid antibodies are directed against a complex antigen that includes a lipid-binding inhibitor of coagulation: β2-glycoprotein-1 (apoprotein H). Proc Natl Acad Sci USA 1990;87:4120-4.
42. Galli M, Comfurius F, Maasen C, Hemker HC, De Baets MH, Van Breda-Vriesman PJC, Barbui T, Zwaal RFA, Bevers EM. Anticardiolipin antibodies (ACA) directed not to cardiolipin but to plasma protein cofactor. Lancet 1990;1:1544-7.
43. Exner T, Triplett DA, Taberner D, Machin SJ. Scientific and Standardization Committee Communications. Guidelines for testing and revised criteria for lupus anticoagulants. SSC Subcommittee for the Standardization of Lupus Anticoagulants. Thromb Haemost 1991;65:320-2.
44. Triplett DA. Laboratory diagnosis of lupus anticoagulants. Semin Thromb Haemost 1990;16:182-90.
45. Rosner E, Pauzer R, Lusky A, Modan M, Many A. Detection and quantitative evaluation of lupus circulating anticoagulant activity. Thromb Haemost 1987;57:144-7.
46. Exner T, Triplett D, Taberner DA, Howard MA, Harris EN. Scientific and Standardization Committee Communications. Comparison of test methods for the lupus anticoagulant: international survey on lupus anticoagulants-1 (ISLA-1). Thromb Haemaost 1990;64:478-84.
47. Exner T, Richard KA, Kronenberg HA. A sensitive test demonstrating lupus anticoagulant and its behavioural pattern. Br J Haematol 1978;40:143-51.
48. Shi W, Chong BH, Chesterman CN. Beta2-glycoprotein I is a requirement for anticardiolipin antibodies binding to activated platelets: differences with lupus anticoagulants. Blood 1993;81:1255-62.
49. Drenkard C, Sanchez-Guerrero J, Alarcon-Segovia D. Fall in antiphospholipid antibody at time of thrombosis in systemic lupus erythematosus. J Rheumatol 1989; 16:614-17.
50. Gattorno M, Picco P, Molinari AC, Buoncompagni A, Naselli A, Mori PG, Pistoia V. Transient disappearance of serum antiphospholipid antibodies during the course of a thrombotic event in two adolescents with antiphospholipid syndrome receiving prednisone. Clin Exp Rheumatol 1994;12:460-1.
51. Sthoeger Z, Sthoeger D, Green L, Geltner D. The role of anticardiolipin autoantibodies in the pathogenesis of autoimmune hemolytic anemia in systemic lupus erythematosus. J Rheumatol 1993;20:2058-61.
52. McNeil HP, Chesterman CN, Krilis SA. Anticardiolipin antibodies and lupus anticoagulants comprise separate antibody subgroup with different phospholipid binding characteristics. Br J Haematol 1989;73:506-13.
53. Galli M, Barbui T, Comfurius P, Zwaal RFA, Bevers EM. Anticoagulant activity of β2-glycoprotein I is potentiated by a distinct subgroup of anticardiolipin antibodies. Thromb Haemost 1992;68:297-300.
54. Hunt JE, Simpson RJ, Krilis SA. Identification of a region of β-glycoprotein I critical for lipid binding and anticardiolipin co-factor activity. Proc Natl Acad Sci USA 1990;2141–5.
55. Asherson RA, Baguley E, Chobie P, Hughes GRV. Antiphospholipid syndrome: five years follow up. Ann Rheum Dis 1991;50:805-10.
56. Derlcsen RHWM, Biesma D, Bouma BN, Gmelig Meyling FHJ, Kater L. Discordant effects of prednisone on anticardiolipin antibodies and the lupus anticoagulant. Arthritis Rheum 1989;29:1295-6.
57. Out HJ, Van Vliet M, De Groot PhG, Derksen RHWM. Prospective study of fluctuation of lupus anticoagulant activity and anticardiolipin antibody titre in patients with systemic lupus erythematosus. Ann Rheum Dis 1992;51:353-7.
58. Derksen RHWM, Hasselaar P, Blockzijl L, Gmelig Meyling FHJ, De Groot PhG. Coagulation screen is more specific than the anticardiolipin antibody ELISA in defining a thrombotic subset of lupus patients. Ann Rheum Dis 1988;47:364-71.
59. MacHugh NJ, Moye DAH, James IE, Sampson M, Maddison PJ. Lupus anticoagulant: clinical significance in anticardiolipin positive patients with systemic lupus erythematosus. Ann Rheum Dis 1991;50:548-52